Astellas Pharma sNDA in Japan for PADCEV in combination with Keytruda for cisplatin-eligible patients with...

The sNDA for Sacituzumab Tirumotecan in combination with Pembrolizumab as 1L treatment for PD-L1 positive...

HS-20093 granted Breakthrough Therapy Designation by NMPA for Esophageal cancer treatment

SYS6010 has received another BTD in China for the treatment of patients with locally advanced...

Emiltatug Ledadotin has been granted Breakthrough Therapy Designation by the U.S. FDA for the treatment...

Zai Lab announced that Zocilurtatug Pelitecan has received U.S. FDA FTD for the treatment of...